Stockreport

Beta Bionics to Announce Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026

Beta Bionics, Inc.  (BBNX) 
PDF IRVINE, Calif., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, [Read more]